Skip to content

Post Stroke Psychological Distress

Depression and Posttraumatic Stress Disorder in Stroke Patients: an Observational Study of Neuro-psychiatric, Cognitive, and MR-Changes Over Time After Stroke

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01187342
Acronym
POSTPSYDIS
Enrollment
84
Registered
2010-08-24
Start date
2009-10-31
Completion date
2015-01-31
Last updated
2025-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Stroke

Brief summary

Neuro-psychological, cognitive and biochemical assessment matched with MR-Imaging in acute and chronic poststroke conditions.

Detailed description

The study design relates to affective symptomatology, particularly poststroke depression and posttraumatic stress symptoms as well as to cognitive decline due to stress-related hypercortisolemia in the early phase after stroke. Extended MRI studies including a functional connectivity (fc-MRI) paradigm have been incorporated to study on subacute midbrain neurodegeneration as a possible morphological correlate of functional and clinical findings.

Interventions

None listed

Sponsors

German Federal Ministry of Education and Research
CollaboratorOTHER_GOV
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Stroke in MCA/AchA territory of striato-capsular (at least 125mm³) or non-striatal (10-100cm³) involvement * MR-imaging can be conducted 24-48 hours of onset * preserved communication skills

Exclusion criteria

* Patients with psychiatric conditions or medication in the last 4 weeks * severe medical conditions * limited prognosis

Design outcomes

Primary

MeasureTime frameDescription
occurence of depression (GDS, SKID)90 daysGeriatric Depression Scale, Structured Clinical interview for DSM-IV

Secondary

MeasureTime frameDescription
change in saliva cortisol90daysmeasurement of saliva cortisol levels
change in serumcholine90daysmeasurement of serumcholine

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026